Journal of Contemporary Brachytherapy
eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
Original paper

Computed tomography-based customized surface mould high-dose-rate brachytherapy for non-melanoma skin cancer of the scalp and face. Long-term results: Optimizing for reduction of late toxicity and improving cosmetic outcome

Anis Bandyopadhyay
1
,
Arnab Kumar Ghosh
2
,
Poulomi Basu
3
,
Poulomi Ghosh
1
,
Priyanka Das
1
,
Bappaditya Chhatui
4
,
Jayanta Kumar Pal
5

  1. Department of Radiotherapy, NRS Medical College and Hospital, Kolkata, India
  2. Department of Radiation Oncology, All India Institute of Medical Sciences, Kalyani, West Bengal, India
  3. Department of Medical Oncology, Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India
  4. Department of Radiotherapy, Medical College Kolkata, Kolkata, India
  5. Medical Physics Department, Department of Radiotherapy, Medical College Kolkata, Kolkata, India
J Contemp Brachytherapy 2026
DOI: https://doi.org/10.5114/jcb.2026.161245
Online publish date: 2026/04/24
Article files
- Computed tomography.pdf  [0.61 MB]
- Computed tomography - supplementary table.pdf  [0.03 MB]
Get citation
 
 
1. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992; 327: 1649-1662.
2. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 Suppl 61: 1-6.
3. Introduction to skin cancer – PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/18088772/ (cited 2023 Mar 6)
4. Labani S, Asthana S, Rathore K, Sardana K. Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions. J Cancer Res Ther 2021; 17: 906.
5. What are the treatment options for non-melanoma skin cancer? In: InformedHealth.org [Internet]. Institute for Quality and Efficiency in Health Care (IQWiG); 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK321128/ (cited 2023 Sep 26).
6. Taggar AS, Mann P, Stewart A et al. Acute and late complications and toxicities of skin brachytherapy. Brachytherapy 2021; 20: 1041-1052.
7. Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol 2021; 96: 263-277.
8. Veness MJ, Delishaj D, Barnes EA et al. Current role of radiotherapy in non-melanoma skin cancer. Clin Oncol (R Coll Radiol) 2019; 31: 749-758.
9. Nguyen TH, Ho DQD. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3: 193-203.
10. Schmook T, Stockfleth E. Current treatment patterns in non-melanoma skin cancer across Europe. J Dermatol Treat 2003; 14 Suppl 3: 3-10.
11. Chakrabarty A, Geisse JK. Medical therapies for non-melanoma skin cancer. Clin Dermatol 2004; 22: 183-188.
12. Non-surgical treatment of skin cancer – PubMed [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/15859300/ (cited 2023 Mar 6).
13. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 2007; 4: 462-469.
14. Ouhib Z, Kasper M, Calatayud JP et al. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy 2015; 14: 840-858.
15. Likhacheva A, Awan M, Barker CA et al. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an american society for radiation oncology clinical practice guideline. Pract Radiat Oncol 2020; 10: 8-20.
16. Rodríguez S, Arenas M, Gutierrez C et al. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy. Clin Transl Oncol 2018; 20: 431-442.
17. Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
18. Shah C, Ouhib Z, Kamrava M et al. The American Brachytherapy society consensus statement for skin brachytherapy. Brachytherapy 2020; 19: 415-426.
19. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
20. Vuyk HD, Lohuis PJ. Mohs micrographic surgery for facial skin cancer. Clin Otolaryngol Allied Sci 2001; 26: 265-273.
21. Johnstone AS. An adhesive applicator for radium therapy. Br J Radiol 1935; 8: 298-305.
22. Karolis C, Reay-Young PS, Walsh W, Velautham G. Silicone plesiotherapy molds. Int J Radiat Oncol Biol Phys 1983; 9: 569-573.
23. Ashby MA, Pacella JA, de Groot R, Ainslie J. Use of a radon mould technique for skin cancer: results from the Peter MacCallum Cancer Institute (1975-1984). Br J Radiol 1989; 62: 608-612.
24. Taylor RG. Depth dosimetry of curved radon-222 plesiotherapy applicators. Australas Phys Eng Sci Med 1983; 6: 94-95.
25. Griep C, Davelaar J, Scholten AN et al. Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1347-1350.
26. Tagliaferri L, Ciardo FG, Fionda B et al. Non-melanoma skin cancer treated by contact high-dose-rate radiotherapy (brachytherapy): a mono-institutional series and literature review. In Vivo 2021; 35: 2313-2319.
27. Guix B, Finestres F, Tello J et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
28. Montero A, Hernanz R, Capuz AB et al. High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol 2009; 11: 760-764.
29. Brovchuk S, Park SJ, Shepil Z et al. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique. J Contemp Brachytherapy 2022; 14: 107-114.
30. Esmati E, Abyaneh R, Jaberi R et al. Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysis. J Contemp Brachytherapy 2024; 16: 323-334.
31. Casey S, Awotwi-Pratt J, Bahl G. Surface mould brachytherapy for skin cancers: The British Columbia Cancer Experience. Cureus 2019; 11: e6412.
32. Gauden R, Pracy M, Avery AM et al. HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol 2013; 57: 212-217.
33. Tormo A, Celada F, Rodriguez S et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
34. Laliscia C, Fuentes T, Coccia N et al. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience. Contemp Oncol 2021; 25: 12-16.
35. Kalaghchi B, Esmati E, Ghalehtaki R et al. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study. J Contemp Brachytherapy 2018; 10: 115-122.
36. Kanikowski M. HDR brachytherapy of skin cancer in material of Greater Poland Cancer Center. J Contemp Brachytherapy 2009; 1: 197.
37. Arenas M, Arguís M, Díez-Presa L et al. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy 2015; 14: 859-865.
38. Lee CT, Lehrer EJ, Aphale A et al. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. Cancer 2019; 125: 3582-3594.
39. Bilski M, Cisek P, Baranowska I et al. Brachytherapy in the treatment of non-melanoma skin peri-auricular cancers – a retrospective analysis of a single institution experience. Cancers 2022; 14: 5614.
40. Villalba SR, Guirado LLorente D, Cazorla AS et al. HDR brachytherapy in keratinocyte skin carcinomas – Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicity. Brachytherapy 2023; 22: 108-119.
41. Bielęda G, Chicheł A, Boehlke M et al. 3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results. J Contemp Brachytherapy 2022; 14: 205-214.
42. Ricotti R, Vavassori A, Bazani A et al. 3D-printed applicators for high dose rate brachytherapy: Dosimetric assessment at different infill percentage. Phys Med 2016; 32: 1698-1706.
43. Poltorak M, Banatkiewicz P, Poltorak L et al. Individualized 3D printing for skin cancer brachytherapy: Development, implementation, clinical applications, and treatment assessment. J Contemp Brachytherapy 2024; 16: 173-183.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.